Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bakish

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Psychiatry & Neuroscience : JPN|August 15, 2002
The neurobiology of treatment response to antidepressants and mood stabilizing medicationsL Trevor Young, David Bakish, Serge Beaulieu
Neuroreport|October 16, 2004
MAO-A gene polymorphisms are associated with major depression and sleep disturbance in malesLisheng Du, David Bakish, Arun Ravindran, et al.
Journal of Psychiatry & Neuroscience : JPN|August 15, 2002
Assessing full remissionRoger McIntyre, Sidney Kennedy, R Michael Bagby, et al.
Journal of Affective Disorders|August 9, 2002
Does fluoxetine influence major depression by modifying five-factor personality traits?Lisheng Du, David Bakish, Arun V Ravindran, et al.
The International Journal of Neuropsychopharmacology|September 28, 2004
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant responseSylvie Lemonde, Lisheng Du, David Bakish, et al.
The International Journal of Neuropsychopharmacology|May 10, 2001
Tryptophan hydroxylase gene 218A/C polymorphism is not associated with depressed suicideLisheng Du, Gabor Faludi, Miklos Palkovits, et al.
Neuroreport|August 2, 2002
High activity-related allele of MAO-A gene associated with depressed suicide in malesLisheng Du, Gabor Faludi, Miklos Palkovits, et al.
Journal of Psychiatry & Neuroscience : JPN|October 23, 2013
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled studyDavid Bakish, Anjana Bose, Carl Gommoll, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2003
Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicideSylvie Lemonde, Gustavo Turecki, David Bakish, et al.
Journal of Women'S Health (2002)|September 23, 2010
Cutoff score of the sexual interest and desire inventory-female for diagnosis of hypoactive sexual desire disorderAnita H Clayton, Robert T Segraves, David Bakish, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Psychiatry & Neuroscience : JPN|August 15, 2002
The neurobiology of treatment response to antidepressants and mood stabilizing medicationsL Trevor Young, David Bakish, Serge Beaulieu
Neuroreport|October 16, 2004
MAO-A gene polymorphisms are associated with major depression and sleep disturbance in malesLisheng Du, David Bakish, Arun Ravindran, et al.
Journal of Psychiatry & Neuroscience : JPN|August 15, 2002
Assessing full remissionRoger McIntyre, Sidney Kennedy, R Michael Bagby, et al.
Journal of Affective Disorders|August 9, 2002
Does fluoxetine influence major depression by modifying five-factor personality traits?Lisheng Du, David Bakish, Arun V Ravindran, et al.
The International Journal of Neuropsychopharmacology|September 28, 2004
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant responseSylvie Lemonde, Lisheng Du, David Bakish, et al.
The International Journal of Neuropsychopharmacology|May 10, 2001
Tryptophan hydroxylase gene 218A/C polymorphism is not associated with depressed suicideLisheng Du, Gabor Faludi, Miklos Palkovits, et al.
Neuroreport|August 2, 2002
High activity-related allele of MAO-A gene associated with depressed suicide in malesLisheng Du, Gabor Faludi, Miklos Palkovits, et al.
Journal of Psychiatry & Neuroscience : JPN|October 23, 2013
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled studyDavid Bakish, Anjana Bose, Carl Gommoll, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2003
Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicideSylvie Lemonde, Gustavo Turecki, David Bakish, et al.
Journal of Women'S Health (2002)|September 23, 2010
Cutoff score of the sexual interest and desire inventory-female for diagnosis of hypoactive sexual desire disorderAnita H Clayton, Robert T Segraves, David Bakish, et al.
Pageof 2